Subscribe to RSS
DOI: 10.1055/s-2001-17132
Recurrent Cholangitis Following “Successful” Treatment for Gallbladder Cancer
In this series we ask one or more experts to review a case. They are provided with information on which further management is to be based, and asked to explain their rationale, using the available evidence in the literature. What was actually done in the case is then revealed.Publication History
Publication Date:
31 December 2001 (online)
Moderator's Introduction
I am very pleased to introduce our guest discussant, Dr Robert Enns, MD, of Vancouver, Canada. A former graduate of the Duke Biliary Sweat Shop, Dr Enns has gone on to distinguish himself as an expert of hepatobiliary and pancreatic disorders in the Canadian gastroenterology community. His particular interests include the use of magnetic resonance imaging to study the pancreas and bile ducts, primary sclerosing cholangitis (PSC), and the management of complications of endoscopic retrograde cholangiopancreatography (ERCP). Welcome, Dr Enns.
References
- 1 Mahe M, Stampfli C, Romestaing P, et al. Primary carcinoma of the gall-bladder: potential for external radiation therapy. Radiother Oncol. 1994; 33 204-208
- 2 Todoroki T, Kawamoto T, Otsuka M, et al. Benefits of combining radiotherapy with aggressive resection for stage IV gallbladder cancer. Hepatogastroenterology. 1999; 46 1585-1591
- 3 Uno T, Itami J, Aruga M, et al. Primary carcinoma of the gallbladder: role of external beam radiation therapy in patients with locally advanced tumor. Strahlenther Onkol. 1996; 172 496-500
- 4 Abi-Rached B, Neugut A I. Diagnostic and management issues in gallbladder carcinoma [review]. Oncology (Huntingt). 1995; 9 19-24
- 5 Bartlett D L, Fong Y, Fortner J G, et al. Long-term results after resection for gallbladder cancer. Implications for staging and management [review]. Ann Surg. 1996; 224 639-646
- 6 Benoist S, Panis Y, Fagniez P L. Long-term results after curative resection for carcinoma of the gallbladder. French University Association for Surgical Research. Am J Surg. 1998; 175 118-122
- 7 de Aretxabala X X, Roa I, Burgos L. Gallbladder cancer, management of early tumors [review]. Hepatogastroenterology. 1999; 46 1547-1551
- 8 Porayko M K, La Russo N F, Wiesner R H. Primary sclerosing cholangitis [abstract]. Semin Liver Dis. 1991; 11 5-10
- 9 Majoie C BLM, Huibregtse K, Weeders J WAJ. Primary sclerosing cholangitis [abstract]. Abdom Imaging. 1997; 22 194-198
- 10 Lee J G, Leung J W, Baillie J, et al. Benign, dysplastic or malignant - making sense of endoscopic bile duct brush cytology: results in 149 consecutive patients. Am J Gastroenterol. 1995; 9 722-726
- 11 Wiesner R H. Current concepts in primary sclerosing cholangitis [review]. Mayo Clin Proc. 1994; 69 969-982
- 12 Lee J G, Schutz S M, England R E, et al. Endoscopic therapy of sclerosing cholangitis. Hepatology. 1995; 21 661-667
- 13 van Milligen de Wit A W, van Bracht J, Rauws E A, et al. Endoscopic stent therapy for dominant extrahepatic bile duct strictures in primary sclerosing cholangitis. Gastrointest Endosc. 1996; 44 293-299
- 14 von Schonfeld J, Lange R, Bug R, Erhard J. Liver transplantation in a 29-year-old patient with gallbladder carcinoma complicating primary sclerosing cholangitis. Z Gastroenterol. 1998; 36 977-981
R. Enns, M.D., F.R.C.P.
St. Paul's Hospital
University of British Columbia
#300-1144 Burrard St
Vancouver BC
Canada VbK 2A5
Fax: + 1-604-689-2004
Email: renns@interchange.ubc.ca
J. Baillie, M.B., Ch.B., F.R.C.P.
Duke University Medical Center
Box 3189
Durham, North Carolina 27 710
USA
Fax: + 1-919-684-4695/681-8785
Email: baill001@mc.duke.edu